These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1140 related items for PubMed ID: 1566771

  • 1. Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices.
    Sivin I, Stern J, Diaz S, Pavéz M, Alvarez F, Brache V, Mishell DR, Lacarra M, McCarthy T, Holma P.
    Am J Obstet Gynecol; 1992 Apr; 166(4):1208-13. PubMed ID: 1566771
    [Abstract] [Full Text] [Related]

  • 2. Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study.
    Sivin I, el Mahgoub S, McCarthy T, Mishell DR, Shoupe D, Alvarez F, Brache V, Jimenez E, Diaz J, Faundes A.
    Contraception; 1990 Oct; 42(4):361-78. PubMed ID: 2124179
    [Abstract] [Full Text] [Related]

  • 3. Two years of intrauterine contraception with levonorgestrel and with copper: a randomized comparison of the TCu 380Ag and levonorgestrel 20 mcg/day devices.
    Sivin I, Stern J, Diaz J, Diaz MM, Faundes A, el Mahgoub S, Diaz S, Pavez M, Coutinho E, Mattos CE.
    Contraception; 1987 Mar; 35(3):245-55. PubMed ID: 3111785
    [Abstract] [Full Text] [Related]

  • 4. An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs.
    Chi IC.
    Contraception; 1991 Dec; 44(6):573-88. PubMed ID: 1773615
    [Abstract] [Full Text] [Related]

  • 5. The performance of levonorgestrel rod and Norplant contraceptive implants: a 5 year randomized study.
    Sivin I, Campodonico I, Kiriwat O, Holma P, Diaz S, Wan L, Biswas A, Viegas O, el din Abdalla K, Anant MP, Pavez M, Stern J.
    Hum Reprod; 1998 Dec; 13(12):3371-8. PubMed ID: 9886517
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Return of fertility following discontinuation of Norplant-II subdermal implants. ICMR Task Force on Hormonal Contraception.
    Buckshee K, Chatterjee P, Dhall GI, Hazra MN, Kodkany BS, Lalitha K, Logambal A, Manchanda P, Nanda UK, RaiChoudhury G.
    Contraception; 1995 Apr; 51(4):237-42. PubMed ID: 7796589
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hormonal intrauterine devices.
    Rybo G, Andersson K, Odlind V.
    Ann Med; 1993 Apr; 25(2):143-7. PubMed ID: 8489751
    [Abstract] [Full Text] [Related]

  • 10. A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls.
    Bahamondes L, Brache V, Meirik O, Ali M, Habib N, Landoulsi S, WHO Study Group on Contraceptive Implants for Women.
    Hum Reprod; 2015 Nov; 30(11):2527-38. PubMed ID: 26409014
    [Abstract] [Full Text] [Related]

  • 11. Return to fertility after removal of a levonorgestrel-releasing intrauterine device and Nova-T.
    Andersson K, Batar I, Rybo G.
    Contraception; 1992 Dec; 46(6):575-84. PubMed ID: 1493717
    [Abstract] [Full Text] [Related]

  • 12. Prolonged intrauterine contraception: a seven-year randomized study of the levonorgestrel 20 mcg/day (LNg 20) and the Copper T380 Ag IUDS.
    Sivin I, Stern J, Coutinho E, Mattos CE, el Mahgoub S, Diaz S, Pavez M, Alvarez F, Brache V, Thevenin F.
    Contraception; 1991 Nov; 44(5):473-80. PubMed ID: 1797462
    [Abstract] [Full Text] [Related]

  • 13. Five years' experience with levonorgestrel-releasing IUDs.
    Luukkainen T, Allonen H, Haukkamaa M, Lähteenmäki P, Nilsson CG, Toivonen J.
    Contraception; 1986 Feb; 33(2):139-48. PubMed ID: 3084167
    [Abstract] [Full Text] [Related]

  • 14. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.
    Luukkainen T, Toivonen J.
    Contraception; 1995 Nov; 52(5):269-76. PubMed ID: 8585882
    [Abstract] [Full Text] [Related]

  • 15. Continuation rates of long-acting methods of contraception. A comparative study of Norplant implants and intrauterine devices.
    Fleming D, Davie J, Glasier A.
    Contraception; 1998 Jan; 57(1):19-21. PubMed ID: 9554246
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system.
    Suvisaari J, Lähteenmäki P.
    Contraception; 1996 Oct; 54(4):201-8. PubMed ID: 8922872
    [Abstract] [Full Text] [Related]

  • 18. Intrauterine devices. The optimal long-term contraceptive method?
    Fortney JA, Feldblum PJ, Raymond EG.
    J Reprod Med; 1999 Mar; 44(3):269-74. PubMed ID: 10202746
    [Abstract] [Full Text] [Related]

  • 19. Acceptability of Norplant-2 rods as a method of family planning.
    Singh K, Viegas OA, Ratnam SS.
    Contraception; 1992 May; 45(5):453-61. PubMed ID: 1623717
    [Abstract] [Full Text] [Related]

  • 20. Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial.
    Andersson K, Odlind V, Rybo G.
    Contraception; 1994 Jan; 49(1):56-72. PubMed ID: 8137626
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 57.